摘要
肺动脉高压(PAH)是由不同致病机制导致的、以肺循环压力和肺血管阻力升高为主要特点,主要病理表现是血管收缩、血管重构和原位血栓的形成,最终导致右心负荷增大或心功能不全、肺血流量明显减少,严重影响患者生活质量和预后效果。近年来,PAH的研究在包括分类、致病机制、诊断和治疗等方面均有重大突破.为临床指导治疗肺动脉高压奠定了坚实的基础。
Pulmonary hypertension(PAH) is different pathogenic mechanisms leading to the lungs pulmonary circulation pressure and pulmonary vascular resistance increases as the main features of the main pathology is vasoconstriction, vascular remodeling and in situ thrombosis, eventually leading to right heart load increase large or heart failure, pulmonary blood flow was significantly reduced,seriously affecting the quality of life and prognosis of patients. In recent years, PAH studies include classification, pathogenesis, diagnosis and treatment and other aspects are a major breakthrough. For the treatment of pulmonary arterial hypertension clinical guidelines laid a solid foundation
出处
《黑龙江医药》
CAS
2015年第1期26-28,29,共4页
Heilongjiang Medicine journal
关键词
肺动脉高压
分类
致病机制
Pulmonary hypertension
classification
pathogenic mechanisms
